In addition, studies have found that gemcitabine can inhibit the growth of pancreatic cancer cells by decreasing PVT1 levels and increasing PVT1 encoded miRNAs, such as the miR-1207 pair (miR-1207-5p/3p) [156, 157]. Here, PVT1 is linked to familial pancreatic carcinoma.